
    
      Skins biopsies from psoriatic skin and blood samples will be taken before (day 0) and at
      several time points after start (day 4, week 2-3, and week 6-7) of dithranol therapy to be
      subjected to an explorative analysis (see outcome measures). A total of maximal 15 psoriasis
      patients will be enrolled. Normal lesion-adjacent skin from 10 patients undergoing surgery
      for non-inflammatory conditions will serve as control.
    
  